• MindWave Innovations is sharpening its focus around a blockchain ecosystem built on MindChain, NILA, MindWaveDAO and a growing network of specialized Subnets.
• At the center of the strategy is MindChain, an Ethereum-compatible Layer 2 designed to provide the underlying infrastructure for the company’s broader ecosystem.
• Together, MindChain, NILA and MindWaveDAO form an interconnected framework through which MindWave aims to support scalable blockchain activity and specialized use cases.

Rather than pursuing a broad collection of digital-asset initiatives, MindWave Innovations Inc. (NYSE American: APUS) is concentrating its efforts around a defined blockchain ecosystem. The company’s current strategy centers on four interconnected components: MindChain, its native NILA token, MindWaveDAO and a Subnet architecture designed to support specialized blockchain environments.

That structure puts MindChain at the foundation of the company’s strategy. MindWave is developing the network as an Ethereum-compatible Layer 2, creating the underlying infrastructure on which the rest of the ecosystem can operate. NILA is intended to function as the network’s native asset, while MindWaveDAO provides a decentralized organizational and community layer and Subnets can enable more specialized blockchain environments.

This creates a connection between the blockchain and its underlying community. Rather than functioning as a standalone digital asset, NILA is being positioned as an integral component of the infrastructure MindWave is building around MindChain.

Supporting that ecosystem is MindWaveDAO, which serves as the decentralized organizational and community layer around the platform. The DAO is intended to support participation across the broader MindWave ecosystem while providing a framework through which users and stakeholders can engage with the network.

MindChain’s Subnet architecture adds another layer to the strategy by creating specialized environments for different applications. Examples include ALCI, which uses AI-driven analytics, blockchain verification and ecosystem data to tokenize environmental services into traceable financial assets; Nexus Global Partners, which focuses on tokenizing and managing institutional real estate assets through blockchain-enabled infrastructure; and BlockAssure, which is developing blockchain-powered insurance infrastructure across life annuity and non-life insurance. Together, these initiatives illustrate how MindChain’s architecture could support distinct use cases while remaining connected to a broader blockchain ecosystem.

Together, they form the foundation of MindWave’s effort to develop an integrated digital-asset ecosystem with infrastructure that can support different participants and applications.

For MindWave, the opportunity lies in developing this infrastructure as blockchain adoption continues to mature. The company is moving its focus toward the underlying network, token and ecosystem needed to support participation in a more scalable and specialized digital economy.

As MindChain progresses toward its planned mainnet launch, the development of NILA, MindWaveDAO and the Subnet architecture will be key components to watch as MindWave works to establish its blockchain ecosystem and position itself within the broader evolution of institutional digital-asset infrastructure.

For more information, visit the company’s website at www.MindWaveDAO.com.

NOTE TO INVESTORS: The latest news and updates relating to APUS are available in the company’s newsroom at https://ibn.fm/APUS

• SS Innovations is scaling its SSi Mantra surgical robotic system from an established Indian base into international markets.
• Second-quarter revenue rose 39.4% year over year to $13.9 million, while 30 SSi Mantra systems were installed during the quarter.
• The company entered the second half of 2026 with 224 systems installed across 12 countries and more than 12,000 cumulative procedures.
• Potential regulatory clearance in the United States and CE marking in Europe could materially enlarge SSII’s addressable market.
• The investment case is seen as attractive because SSII is still early in its commercialization curve, although investors must weigh cash consumption, regulatory risk, and potential dilution against its growth prospects.

SS Innovations International (NASDAQ: SSII), a developer of innovative surgical robotic technologies, presents an attractive proposition for investors in the medical-technology sector. The company’s SSi Mantra system is being deployed at an increasing number of hospitals, surgeons are performing thousands of procedures with the platform, and SSII is beginning to establish an installed base outside its home market.

The latest quarterly figures show a company rapidly expanding from a relatively small original base. SSII reported second-quarter revenue of $13.9 million, an increase of 39.4% from the same period a year earlier. It installed 30 SSi Mantra systems during the quarter, compared with 23 in Q2 2025. First-half revenue reached $25 million, up 65.6% year over year.

As of June 30, the cumulative installed base had reached 224 systems across 12 countries. Hospitals using the platform had performed 12,272 procedures, including 637 cardiac operations, 222 pediatric procedures and 175 telesurgeries.

Those numbers provide important context for a recent Seeking Alpha analysis by Eborose Capital, which argues that SSII offers investors a potentially more asymmetric opportunity than the much larger Intuitive Surgical (NASDAQ: ISRG) (https://ibn.fm/Y2kq3).

The comparison is useful, but the more important point is what it says about SSII itself. Intuitive Surgical has an enormous installed base and a mature recurring-revenue model built around its da Vinci platform. SS Innovations is at an earlier stage. Its installed base is much smaller, but that also means there is considerably more room for expansion if the company can continue converting hospitals and surgeons to its technology.

The growth differential is already visible. SSII’s installed base increased from 105 systems at the end of Q2 2025 to 224 one year later, while quarterly procedures climbed from 1,042 to 2,528. System sales generated $12.4 million of Q2 revenue, up 40.8% year over year.

For an emerging medical-device company, utilization is particularly important. Selling a robot creates the installed base; procedures performed on that robot create opportunities for recurring instrument and service revenue. That is one reason SSII’s longer-term economics could look different from today’s revenue mix.

It would be a mistake, however, to characterize SS Innovations simply as a lower-cost alternative to Intuitive Surgical. Price is part of the company’s strategy, particularly in India and other healthcare markets where the capital cost of robotic surgery can limit adoption. But the more significant investment argument is whether SSi Mantra provides the capabilities hospitals and surgeons actually require.

The company’s current SSi Mantra 3 platform incorporates an open-face surgeon console with a large 3D 4K monitor, ergonomic hand controls and head-tracking technology. Its patient-side carts are modular, while the vision cart incorporates 3D 4K imaging and other operating-room equipment.

SS Innovations also supports multiple specialties, including urology, gynecology, general surgery, thoracic surgery and cardiac surgery. The company says the system is designed to give surgeons flexibility in configuring the robotic arms according to the procedure. That breadth is important because the economic value of a surgical robot ultimately depends on utilization. As an example of its growing utilization, a medical team in India utilized the SSi Mantra surgical robotic systems to successfully complete fifty gastric bypass procedures in a single day, demonstrating the robustness of the company’s technology.

India is particularly significant to the SSII story. The country has a huge population and a healthcare system in which access to advanced medical technology varies considerably between institutions and regions. SS Innovations has built its commercial operation in that environment rather than waiting for entry into the world’s largest developed healthcare markets. That has allowed the company to establish clinical experience while expanding its installed base.

The company’s own development history also provides a degree of credibility. Founder, Chairman and CEO Dr. Sudhir Srivastava is a robotic cardiac surgeon, and the company’s technology has been developed with applications in cardiac surgery alongside other specialties. SS Innovations also operates a training infrastructure intended to help surgeons transition to robotic procedures.

Telesurgery adds another dimension. In July, surgeons used SSi Mantra to conduct a robotic sleeve gastrectomy between Colombia and India across more than 13,600 miles of fiber-network distance, according to the company’s SEC filing.

The biggest potential change to SSII’s growth profile could come from outside India. The company is pursuing U.S. FDA 510(k) clearance and European CE marking for SSi Mantra. Those approvals would give SSII access to markets where robotic surgery is already well established and where hospitals have demonstrated willingness to invest in robotic-assisted procedures.

Importantly, much of SSII’s current growth has been achieved without access to the U.S. market. If the company eventually receives the necessary regulatory clearances, the potential market expands substantially beyond the countries in which it currently operates.

For more information, visit the company’s website at www.SSInnovations.com.

NOTE TO INVESTORS: The latest news and updates relating to SSII are available in the company’s newsroom at https://ibn.fm/SSII

• Nightfood Holdings, through TechForce Robotics, is expanding from hospitality robotics into AI, automation, and advanced manufacturing.
• The company combines proprietary technology, recurring Robotics-as-a-Service Provider deployments, and strategic acquisitions to create multiple avenues for growth.
• Through its Robotic Connective Network and proposed JJ Enterprise acquisition, NGTF is targeting commercial, industrial, and enterprise automation markets.

Nightfood Holdings (OTCQB: NGTF), doing business as TechForce Robotics, is building toward a broader role in the rapidly evolving automation and robotics economy. What began with a focus on hospitality automation is developing into a more diversified strategy spanning proprietary software, autonomous robotics, enterprise coordination, and advanced manufacturing.

For investors, the appeal of that strategy lies in its multiple layers. TechForce is not simply pursuing revenue from individual robot deployments. The company is developing an ecosystem that combines specialized machines with the software and infrastructure needed to coordinate them, while expanding into higher-value industrial and manufacturing markets.

One of the most significant developments in that evolution is TechForce’s proprietary Robotic Connective Network(TM). Launched in July 2026, the technology framework is designed to enable AI systems, robots, sensors, smart devices, and operational software to communicate and coordinate workflows across connected environments.

At its core is patent-pending decentralized task coordination technology designed to allow connected devices to negotiate task ownership based on real-time factors such as workload, proximity, battery capacity, and operating conditions. The objective is to reduce dependence on continuous human direction while allowing robotic fleets to respond dynamically as circumstances change.

That addresses a growing challenge in enterprise robotics. As organizations deploy multiple specialized machines, the opportunity increasingly extends beyond what any individual robot can accomplish. The next challenge is coordinating those systems so they can work together efficiently. TechForce is positioning its connective technology as part of the infrastructure needed to support that transition.

The company is also pursuing a recurring Robotics-as-a-Service Provider (“RaaSP”) model. Depending on the deployment, TechForce may provide facility assessment, mapping, systems integration, maintenance, technical support, software updates, training, and ongoing optimization. The model is designed to reduce upfront barriers for customers while potentially creating recurring revenue and opportunities to deepen customer relationships over time.

Another major component of Nightfood’s growth strategy is its proposed acquisition of a controlling interest in Jiun Jiang Enterprise Co., Ltd. The Taiwan-based company brings capabilities spanning semiconductor automation, advanced packaging equipment, industrial robotics, logistics, and precision manufacturing. The transaction could significantly broaden Nightfood’s addressable markets beyond service robotics. The companies are also evaluating a potential manufacturing expansion of up to approximately 100,000 square feet across Taiwan and the United States, subject to negotiations, approvals, and other conditions.

Nightfood’s existing hospitality assets add another dimension to the strategy. Beyond their operating and balance-sheet value, the properties can provide real-world environments where TechForce technologies can be tested, validated, and demonstrated under commercial conditions.

Taken together, these initiatives give Nightfood exposure to several interconnected growth themes: AI-enhanced robotics, enterprise automation, recurring RaaSP revenue, multi-robot coordination, semiconductor automation, and advanced manufacturing.

The strategy is not without execution risk, particularly surrounding the proposed JJ Enterprise transaction and future expansion plans. However, if TechForce can successfully connect its robotics, software, RaaSP model, and manufacturing capabilities, Nightfood could evolve from a hospitality-focused robotics company into a more diversified participant in the broader automation economy.

For more information, visit the company’s website at TechForceRobotics.com.

NOTE TO INVESTORS: The latest news and updates relating to NGTF are available in the company’s newsroom at https://ibn.fm/NGTF

Disseminated on behalf of Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) (Frankfurt: W1H) and may include paid advertising.

• Onco-Innovations has advanced ONC010 across API manufacturing, polymer optimization, analytical development, preclinical characterization and clinical planning as it works toward human evaluation.
• A 300-gram development batch of ONC010’s active ingredient achieved approximately 99.3% purity, while a newly identified non-tin catalyst could support improved control of impurities in future polymer manufacturing.
• The company is building an Australian pathway for a potential First-in-Human study while advancing bioanalytical, metabolism, ADME, toxicology, biodistribution and regulatory preparation during the second half of 2026.

Cancer therapies built around DNA damage face a fundamental biological obstacle: cancer cells can repair the very damage meant to destroy them. That has made DNA Damage Response (“DDR”) inhibition an important field in oncology, where the goal is to disable specific repair mechanisms and leave cancer cells more vulnerable to treatment.

Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) (FSE: W1H) is a preclinical-stage company pursuing an emerging target in that field, Polynucleotide Kinase Phosphatase, or PNKP. Its lead candidate, ONC010, pairs a small-molecule PNKP inhibitor with a nanoparticle delivery system. The company’s latest update brings together previously announced advances in API manufacturing, polymer development, analytical controls and preclinical characterization while adding a newly identified non-tin catalyst for the polymer synthesis process. Collectively, the work reflects a program increasingly focused on the manufacturing, preclinical and regulatory infrastructure required for clinical development.

Targeting Cancer’s Repair Machinery

PNKP is involved in the repair of damaged DNA strands. Onco’s strategy is to inhibit that repair process, potentially allowing DNA damage to accumulate in cancer cells.

The approach is designed to work in multiple ways. PNKP inhibition may enhance the effects of DNA-damaging treatments such as radiation and certain chemotherapies, while potentially creating synthetic lethality in cancers carrying specific genetic deficiencies. Onco identifies PTEN and SHP-1 deficiencies among potential synthetic lethal partners.

PARP inhibitors helped establish the broader DDR inhibitor field and are now used to treat several cancers. Onco’s presentation reports that DDR inhibitors generated more than $7 billion in sales during 2025 and positions PNKP as a distinct emerging class beyond PARP.

ONC010 adds nanoparticle delivery to the approach. It encapsulates A83B4C63, Onco’s exclusively licensed small-molecule PNKP inhibitor, inside PEO-b-PBCL, a micellar nanocarrier designed to influence circulation time, tumor accumulation and drug exposure. The delivery system, developed under an exclusive sublicense, represents an additional development challenge because the company must establish not only a reproducible API manufacturing process, but also consistent production of the polymer and resulting nanoparticle formulation.

Building a Reproducible Drug Product

Working with Dalton Pharma Services, Onco advanced ONC010’s active pharmaceutical ingredient from laboratory synthesis through intermediate production and completed a 300-gram development-scale batch of A83B4C63 at approximately 99.3% purity, with residual solvents below the detection limits of the analytical methods employed.

The company also completed an analytical reference-standard preparation program for A83B4C63. The highly characterized material is intended to support future assessment of API identity, purity, stability, impurity profiles and batch-to-batch comparability. Together, these activities are intended to strengthen the analytical controls surrounding future manufacturing, formulation work and clinical-material production.

Polymer manufacturing represents the other critical component of ONC010 because the drug candidate depends on its nanoparticle delivery system. Onco has advanced an analytical method using refractive index detection coupled with gel permeation chromatography to characterize the polymer’s molecular weight, molecular-weight distribution and polydispersity index.

Those characteristics can influence nanoparticle formation, particle-size consistency, drug loading and formulation reproducibility. In parallel, Nanosoft Polymers has been optimizing polymer synthesis, purification and scalability.

The latest development centers on Nanosoft’s identification of a non-tin catalyst for continued polymer-process development. The company expects the approach could support better control of catalyst-related impurities while contributing to a more consistent and reproducible polymer manufacturing process suitable for eventual GMP production. Nanosoft will continue evaluating the catalyst as development progresses.

Preparing for the Clinical Transition

Manufacturing advances are being paired with a growing preclinical program. Nucro-Technics is developing and executing specialized liquid chromatography-mass spectrometry methods to measure A83B4C63 in biological samples generated through Onco’s non-GLP pharmacokinetic and biodistribution animal study.

The resulting analytical capabilities are intended to help characterize compound exposure and distribution while supporting future dosing strategies and planning for subsequent GLP-compliant studies.

Onco has also initiated hepatocyte and liver microsome metabolism studies across human, rat and dog systems. These studies are designed to characterize intrinsic clearance, metabolic degradation and species-specific metabolism, information that can contribute to toxicology-study design, pharmacokinetic modeling, dose selection and regulatory planning.

In July, the company initiated additional absorption, distribution, metabolism and excretion (“ADME”) studies, initially focused on the metabolism of the API used in ONC010. Together, these studies are intended to build a more complete understanding of the candidate’s pharmacokinetic and metabolic profile as the program advances through its IND-enabling work.

That work builds on earlier animal research using nanoparticle formulation. Findings published in the Journal of Controlled Release in 2021 reported slower tumor growth and improved survival in PTEN-deficient models, favorable pharmacokinetics and low observed toxicity, along with sensitization to radiation and topoisomerase I inhibitors. Preclinical results do not establish safety or efficacy in humans, which is precisely why the current transition toward formal clinical development matters.

Australia Provides the Clinical Pathway

Onco has established Onco-Innovations AU Pty. Ltd. as a wholly owned Australian subsidiary and engaged Research & Development Incentives Partners (RDI Partners) to support its Australian operations. The company is also continuing to work with Avance Clinical toward potential Phase I development in Australia.

The Australian structure provides a local operating and governance framework for planned Phase I activities while the company works toward potential submission to a Human Research Ethics Committee and progression through Australia’s Therapeutic Goods Administration Clinical Trial Notification pathway.

The company has also strengthened its scientific and clinical leadership with the appointments of Dr. Islam Mohamed as Chief Medical Officer and Stephen M. Novak as Chief of Research and Development. The additions provide additional oversight across clinical strategy, research planning and coordination with external development partners.

“The ONC010 program is moving from a collection of individual development activities into an increasingly integrated CMC, preclinical and clinical-readiness program,” Mohamed said.

That integration is becoming increasingly important as Onco moves beyond individual laboratory milestones. API manufacturing, polymer development, analytical controls, pharmacokinetic and metabolism studies and clinical planning now need to advance in parallel and ultimately converge into a package capable of supporting human evaluation.

During the second half of 2026, Onco expects to continue manufacturing scale-up, analytical qualification, polymer optimization, toxicology and biodistribution studies, clinical protocol development and regulatory preparation supporting the Australian First-in-Human pathway.

The challenge now is turning years of science into a reproducible drug product supported by the manufacturing controls, preclinical evidence and regulatory documentation required to enter the clinic. If execution continues as planned, the next chapter for ONC010 will be measured less by individual laboratory milestones and more by the company’s ability to translate those pieces into a coordinated pathway toward evaluation in patients.

For more information, visit https://oncoinnovations.com.

NOTE TO INVESTORS: The latest news and updates relating to ONNVF are available in the company’s newsroom at ibn.fm/ONNVF

• The tokenized real-world asset market reached an estimated $60 billion in value across more than 7,000 products by mid-2026.
• In January 2026, Lunar Records, of which HWAL owns 50% through its subsidiary Melody Trust LLC, formed Lunar Records Fund 1, the first tokenized real-world asset fund built around music royalties.

For decades, musicians and songwriters have complained that royalty statements arrive late, are hard to audit and rarely show from whence the money came. HWAL (OTC: HWAL) is taking an innovative approach to that problem using tokenized assets. 

The broader trend HWAL is riding is real and growing quickly. The tokenized real-world asset market reached an estimated $60 billion in value across more than 7,000 products by mid-2026. Much of that growth has centered on tokenized treasuries and commodities, but momentum is spreading into other asset classes as regulatory clarity improves.

Music royalties are a natural candidate for that shift. Traditional royalty accounting relies on layers of intermediaries, from performing rights organizations to distributors, each taking a cut and adding delay before money reaches an artist.

HWAL Inc., a multimedia holding company focused on entertainment, and tokenized real-world assets, is working to shorten that chain. The company’s subsidiary Melody Trust holds rights to a catalog of recordings from major music legends, while its Lunar Records joint venture is now working to license through streaming and blockchain channels.

In January 2026, Lunar Records formed Lunar Records Fund 1, the first tokenized real-world asset fund built around music royalties. The fund is structured to offer Bitcoin-based tokens priced at one dollar each, with an initial raise target of $10 million. Token holders will receive a monthly share of royalties generated by one thousand songs from the underlying catalog. HWAL has said it eventually wants to expand this fund structure to as much as $500 million in assets under management.

Beyond royalties, HWAL is licensing its music catalog not just through traditional avenues, but expanding to film, television, video games, metaverse and commercials, as a meaningful part of its planned revenue strategy going forward.

Through its partnership with Space Blue, HWAL is also connected to the Lunaprise Museum, an archive of music and art carried to the Moon aboard the Odysseus lander in February 2024. NASA confirmed that mission as the first successful American soft landing on the lunar surface since the Apollo program.

HWAL has paired these initiatives with changes to its own governance and structure. In June 2026, the company appointed finance and strategy veteran Jamie Shortill to its board of advisors in preparation for growth across music, sports, broadcast, and digital assets. The company has also said it is working to reduce outstanding debt and has begun a share buyback program.

HWAL is entering the tokenized real-world asset space at an early stage, alongside a broader financial sector that is still taking shape in the United States and abroad. That timing gives the company room to help define how music royalties fit into this emerging model, rather than simply adopting standards set by others.

The combination is distinctive. Few holding companies are simultaneously working across blockchain royalty distribution and licensing. That range reflects a company willing to build into a territory most of its peers in entertainment have yet to explore and could give HWAL a wider set of tools to work with as its various ventures develop.

For more information, visit www.HWAL.net.

NOTE TO INVESTORS: The latest news and updates relating to HWAL are available in the company’s newsroom at https://ibn.fm/HWAL

• For companies seeking to lead the way forward in industrial technology, leadership experience can become a strategic asset equal in importance to the underlying technology itself.
• Cofounder, CEO and chair Matthew McKean’s professional background spans sales, management, finance and entrepreneurship.
• Cofounder and CTO Joseph Witherspoon’s career has been centered on engineering, process design and industrial project execution.

The success of large-scale industrial and energy technologies often depends on more than the technology itself. Companies must also possess the leadership, operational expertise and execution capabilities necessary to move projects from development into commercial operation. Frontieras North America is pursuing that path in the coal sector through its proprietary FASForm(TM) technology platform, which is designed to convert coal into multiple high-value products, while building a management team with experience across engineering, energy, finance and industrial operations.

History shows that commercialization can be one of the most difficult stages in the life cycle of an industrial technology company. The U.S. Department of Energy (“DOE”) notes that technologies often encounter significant risks as they move from development to commercialization, including technical, market, financing and execution challenges that can slow or prevent deployment. DOE materials discussing large-scale commercial demonstrations further explain that moving technologies from pilot projects to commercial operation often requires substantial capital investment and the successful management of project execution risks. Successfully navigating these challenges often requires leadership teams capable of managing complex projects, coordinating and even creating innovation, and securing the capital needed to support growth.

Leadership becomes even more important during periods of industrial transformation. New technologies can create significant opportunities, but companies must still integrate into established markets and supply chains. Experienced executives often bring industry relationships, operational knowledge and capital markets expertise that can help bridge the gap between innovation and commercialization. For companies seeking to lead the way forward in industrial technology, leadership experience can become a strategic asset equal in importance to the underlying technology itself.

As the company moves toward commercial deployment of its proprietary technology, Frontieras has assembled a management team with backgrounds spanning energy, engineering, project development, finance and industrial operations. The company is led by cofounder, CEO and chair Matthew McKean, whose professional background spans sales, management, real estate finance and entrepreneurship, including the cofounding and successful exit of a mortgage banking company. He has also worked as a consultant and peer-group leader with Vistage International, advising business leaders across a wide range of industries, including construction, heavy-equipment leasing, finance, advertising, public relations, private education and consumer goods. This broad business experience provides exposure to many of the operational and strategic challenges companies face as they grow and scale.

McKean’s career reflects the multidisciplinary leadership often required in industrial businesses. While technological innovation is essential, companies must also navigate financing, organizational growth, strategic planning and changing market conditions. McKean’s experience working with executives and business owners across multiple sectors has provided insight into the leadership and decision-making processes that support long-term business development. As Frontieras continues to advance its business objectives, McKean’s combination of entrepreneurial and management experience forms an important part of the company’s leadership foundation.

Working alongside McKean is cofounder and CTO Joseph Witherspoon, P.E., whose career has been centered on engineering, process design and industrial project execution. Witherspoon has held engineering and leadership roles with organizations including Chevron, Enterprise Products, Sinclair Oil and Marathon Petroleum. His experience includes work as a process design engineer and major capital project manager, positions that involved the design, development and implementation of complex industrial systems.

Witherspoon’s background combines technical expertise with practical experience in large-scale industrial operations. Throughout his career, he has worked in petroleum refining, natural gas processing and chemical process engineering, disciplines that require a detailed understanding of industrial production systems and project execution. This blend of engineering and operational knowledge is particularly valuable in industries where moving from concept to commercialization depends on both technical performance and real-world implementation.

A key element of Witherspoon’s contribution to the company is the development of the patent-pending Witherspoon Method(TM), a proprietary process that the company describes as an adjunct to its broader technology platform. According to Frontieras, the method is designed to produce large quantities of ammonium sulfate fertilizer and sulfuric acid  from materials that would otherwise be treated as waste streams. The process reflects Witherspoon’s long-standing focus on finding new ways to extract additional value from industrial feedstocks and process outputs.

Other key members of the Frontieras leadership team include Andrea Moran, Jose Lopez and Bob Portz, each of whom brings specialized expertise that strengthens the company’s ability to execute its long-term growth strategy. Moran officially joined the company in 2022 and contributes extensive experience in debt structuring, project finance and energy-sector financing. Her background in capital formation and strategic financing supports Frontieras’ efforts to advance large-scale infrastructure and industrial development projects.

CFO Jose Lopez joined Frontieras in 2025, bringing decades of public company financial leadership and expertise in corporate finance, regulatory compliance, mergers and acquisitions, and capital markets. His experience helps position the company for disciplined financial management and future growth as it expands its operations. Bob Portz, Frontieras’ newest executive hire, leads operations at the company’s Mason County facility. A veteran refining executive recognized for overseeing Wyoming’s most profitable refinery, Portz brings decades of operational leadership and hands-on experience optimizing refinery performance, safety and efficiency.

In addition to these key executives, board members bring deep expertise in energy policy, large-scale infrastructure construction and corporate finance to Frontieras as the company advances commercialization of its Mason County facility. Board members include John Venners, Jean Abiassi, Stephen R. Boatwright and Rachael Crump.

Venners has more than 40 years of experience building and leading private and public companies in the global energy sector. His career includes serving as director of Congressional and Public Affairs at the White House Office of Emergency Preparedness and founding a company focused on advanced coal beneficiation technologies. His work spans international oil trade, nano solar, hydrogen fuel cells, and water and air purification technologies.

Abiassi is a professional engineer with a career spanning some of the most complex infrastructure projects in the United States. He has served in key positions on numerous major projects and managed the acquisition of the first segment of the East Side Access project in New York City. He also served as president and COO at Zachry Construction Corporation and president and CEO of the Building and Specialty Divisions of Tutor Perini Corporation before returning to consulting and board advisory work.

Boatwright is one of Arizona’s most recognized transactional attorneys, ranked among the best in his field. Over more than three decades, he has negotiated and documented several billion dollars in financing, mergers and acquisitions, and has advised more than 20 companies through public offerings on the NYSE American, NASDAQ and OTCBB.

Crump, a certified public accountant and NACD Directorship Certified board member, brings to Frontieras more than 25 years of financial leadership across Fortune 500 and high-growth organizations as the company advances commercialization of its first FASForm facility in Mason County, West Virginia. Crump will serve as chair of the Board’s Audit Committee.

The leadership team assembled at Frontieras North America illustrates a broader reality across the industrial and energy sectors. Innovative technologies can create significant opportunities, but successful commercialization often depends on the people responsible for guiding those technologies through development, market entry and long-term growth.

Companies that combine technical expertise, operational experience and business leadership are often better positioned to navigate complex markets, manage risk and execute ambitious strategies. Frontieras has built its leadership team around that principle, bringing together expertise in business management, engineering and industrial operations as it pursues its long-term objectives.

For more information about Frontieras, visit the company’s website at www.Frontieras.com.

NOTE TO INVESTORS: The latest news and updates relating to Frontieras are available in the company’s newsroom at https://ibn.fm/Frontieras

• Institutional participation in digital assets is increasingly driving demand for infrastructure built around security, governance and scalability
• MindWave Innovations Inc. focuses on its blockchain ecosystem around MindChain, its NILA token, MindWaveDAO and a network of Subnets
• The company is positioning these components as interconnected elements of its broader strategy to build infrastructure for institutional digital finance

As digital assets continue to develop beyond individual currencies, attention is increasingly turning toward the infrastructure required to support broader participation. For institutions, that means more athan access to digital assets. It requires networks, governance structures and technology capable of supporting participation within an evolving digital economy.

That infrastructure is at the center of MindWave Innovations’ (NYSE American: APUS) positioning. The company describes itself as building the infrastructure layer for institutional digital finance, with its current blockchain strategy centered on MindChain, NILA, MindWaveDAO and its Subnets.

MindChain and Validator Infrastructure

The company’s website identifies MindChain/validator infrastructure as a core solution, describing it as infrastructure designed to support secure, reliable and scalable validator operations for institutional digital assets. 

By focusing on validator infrastructure, MindWave is targeting the technology that supports blockchain participation and network operations rather than solely the digital assets themselves.

That infrastructure also provides the foundation for the broader MindChain ecosystem, including NILA, MindWaveDAO and the company’s Subnet strategy.

NILA and the MindChain Ecosystem

Another central component of MindWave’s strategy is NILA, the company’s digital asset associated with the MindChain ecosystem.

MindWave is developing NILA as part of the broader ecosystem surrounding MindChain rather than as a standalone initiative. That relationship connects the company’s digital-asset strategy with its blockchain infrastructure and broader ecosystem development.

As blockchain ecosystems mature, bringing infrastructure and digital-asset participation together can become an important element of creating sustained network activity.

MindWaveDAO Adds Governance and Participation

According to the company, the DAO serves as the blockchain ecosystem layer within the MindWave platform, supporting governance, staking and digital-asset participation across the broader ecosystem.

That gives MindWaveDAO a distinct role alongside MindChain and NILA: MindChain focuses on blockchain and validator infrastructure, while MindWaveDAO is positioned around governance and participation, with NILA serving as the ecosystem’s digital-asset component.

Together, the initiatives illustrate MindWave’s effort to build an interconnected blockchain ecosystem rather than treat infrastructure, digital assets and participation as separate businesses.

Expanding Through Subnets

MindWave is also incorporating Subnets into its broader MindChain strategy, creating another avenue through which the ecosystem can expand.

While MindChain provides a broader blockchain infrastructure, Subnets can serve as additional environments within the ecosystem as the company’s network develops.

The approach gives MindWave a strategy extending beyond a single blockchain infrastructure layer, with NILA, MindWaveDAO and Subnets representing complementary components of its broader blockchain ecosystem.

Building an Integrated Digital Finance Platform

As institutional participation in digital assets develops, infrastructure capable of supporting secure, scalable and governance-driven participation may become increasingly important.

MindWave is positioning its four core initiatives around that opportunity, with the objective of bringing blockchain infrastructure, digital assets and ecosystem participation together within a unified platform.

For investors, the key consideration will be how effectively the company can develop these components into a functioning ecosystem and translate its infrastructure strategy into sustained participation within the digital-asset economy.

For more information, visit the company’s website at www.MindWaveDAO.com.

NOTE TO INVESTORS: The latest news and updates relating to APUS are available in the company’s newsroom at https://ibn.fm/APUS

Disseminated on behalf of SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) and may include paid advertising.

• The importance of real-time decision-making, resilience in GPS-denied environments, and giving drones and other autonomous systems greater independence are driving demand for advanced intelligence technologies.
• A company positioned at the center of this shift is SPARC AI, which develops GPS-independent target acquisition, positioning and autonomous navigation software for drones and other autonomous systems.
• SPARC AI combines proprietary spatial mathematics, machine learning and sensor fusion to provide positioning and target geolocation capabilities designed to support targeting and navigation when GPS is jammed, spoofed or unavailable.

Whether in defense, rescue or commercial applications, there is growing demand for greater intelligence and autonomy in unmanned systems. A major driver is the increasing prevalence of GPS jamming and spoofing, which can compromise navigation and positioning when satellite signals are degraded or unavailable.

The issue is extending beyond the battlefield. CNN recently reported that GPS interference is creating navigation challenges for aircraft operating near conflict zones, while Sky News reported more than one million GPS-jamming incidents in the Middle East Gulf since the start of the Iran war. The disruption has affected everything from drones and ships to passenger aircraft, highlighting the growing vulnerability of GPS-dependent systems.

For autonomous platforms, this creates a need for positioning and navigation capabilities that can remain effective when GPS is unreliable. Beyond resilience, intelligent autonomous systems can also provide low-latency decision-making and reduce dependence on external infrastructure, helping them operate more effectively in challenging environments.

A company focused on addressing these challenges is SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF). SPARC AI develops GPS-independent target acquisition, positioning and autonomous navigation software for drones and other autonomous systems.

SPARC AI’s flagship Overwatch platform is designed to provide positioning, targeting and intelligence capabilities across drone platforms without relying on GPS. The platform brings together capabilities including target acquisition, navigation and positioning into a software-based system designed for contested environments.

Overwatch can process telemetry from drones and other moving platforms and provide positioning information even when GPS is jammed, spoofed or unavailable. The company’s approach is designed to avoid the need for additional specialized hardware such as radar or lidar, helping reduce the weight, cost and power requirements associated with adding new capabilities to a drone.

At the core of SPARC AI’s technology is a combination of proprietary spatial mathematics, machine learning and sensor fusion. These technologies are designed to extract useful positioning and target information from sensor and telemetry data, supporting navigation and target acquisition in environments where conventional GPS-based systems may not be reliable.

SPARC AI has also continued expanding Overwatch beyond individual aircraft. The platform can bring information from multiple drones onto a shared operating picture, allowing operators to classify and track targets, collaborate and plan missions across connected systems. The company has additionally integrated image recognition into its drone controller application, further expanding the platform’s intelligence capabilities.

More recently, the company launched the Overwatch Positioning Network, which moves GPS-independent positioning into a network-based service. Under the model, drones send available telemetry to Overwatch and receive positioning information back, without requiring additional equipment or software to be installed on the aircraft. The company says the service can return positioning in roughly one-third of a second.

This approach could allow GPS-independent positioning capabilities to scale across fleets without requiring operators to equip each individual aircraft with specialized positioning hardware. SPARC AI is initially deploying the network in Ukraine, where GPS-denied conditions are particularly relevant, while also pursuing opportunities across U.S. and allied defense and public-safety markets.

For more information, visit the company’s website at https://sparcai.co.

NOTE TO INVESTORS: The latest news and updates relating to SPAIF are available in the company’s newsroom at https://ibn.fm/SPAIF

• NGTF’s TechForce Robotics is developing a proprietary network designed to coordinate robots, AI systems and smart devices across connected environments.
• The company’s patent-pending decentralized technology is designed to allow connected machines to negotiate and reassign tasks based on real-time operating conditions, reducing the need for constant human intervention.
• TechForce is applying its automation platform across hospitality, commercial and industrial markets, with a recent NBR Intelligence framework contemplating a nonbinding planning target of up to 5,000 robotic systems.

As robotics adoption accelerates, the challenge is shifting from building individual machines to making increasingly diverse robotic fleets work together. A cleaning robot, delivery robot, industrial arm and laboratory system may each perform its assigned task autonomously, but coordinating those machines across a facility can still require significant human oversight.

That creates an opportunity for the software and connectivity layer sitting between individual machines.

Nightfood Holdings (OTCQB: NGTF), operating through its TechForce Robotics brand, is developing technology around that opportunity. The company’s Robotic Connective Network is designed to allow AI systems, robots, sensors and smart devices to exchange information and coordinate workflows within a common operational environment.

The broader robotics market is already moving toward greater commercial adoption. The International Federation of Robotics reported nearly 200,000 professional service robots sold worldwide in 2024, up 9% year over year, while transportation and logistics robots reached 102,900 units. Robotics-as-a-Service fleets also grew 31%, reflecting increasing demand for automation delivered through recurring service models.

As more robots enter real-world facilities, interoperability and coordination become increasingly important.

Building a Coordination Layer

TechForce’s Robotic Connective Network is designed to address that challenge by creating a common communication and coordination layer between connected machines. Rather than simply allowing different robots to operate alongside one another, the system is intended to help them coordinate workflows and respond to changing conditions.

At the core of the platform is TechForce’s patent-pending decentralized coordination technology. The system is designed to allow connected devices to negotiate task ownership based on factors such as workload, proximity, battery capacity and operating conditions.

That distinction matters because individual robot autonomy does not necessarily create fleet-level autonomy. A robot can independently complete a task while still requiring a human operator to determine what happens next. As fleets grow, that manual coordination can become an operational bottleneck.

TechForce’s approach is intended to address that gap. If one machine completes an assignment, the network could help determine which available robot is best positioned to take on the next task. Likewise, if a machine is approaching low battery or encounters another operating constraint, work could potentially be reassigned to a more suitable unit.

Moving From Technology to Deployment

The opportunity becomes more tangible as TechForce expands its focus beyond hospitality and commercial service robotics into industrial environments.

On August 17, an AINewsWire editorial highlighted TechForce’s recently announced letter of intent with Singapore-based NBR Intelligence Pte. Ltd., which contemplates a nonbinding planning target of up to 5,000 robotic systems for factory automation. The framework begins with five pilot units, with operational, safety, network and workflow assessments preceding any larger deployment.

The proposed program is structured around measurable performance criteria, including availability, task completion, throughput, accuracy and safety. The contemplated robotic mix includes 4- to 6-axis robotic arms alongside TechForce’s LIM-E and Kebb-i platforms, with the company’s targeting automation of up to 30% of identified workflows at participating sites.

The staged approach is significant because industrial robotics requires more than technical capability. Systems must operate reliably within existing facilities, integrate with workflows and demonstrate measurable performance before operators can justify broader deployment.

TechForce’s RaaS model is also designed to lower that adoption barrier. Instead of requiring customers to make a large upfront capital investment, RaaS can shift robotics toward an ongoing operating expense while creating opportunities for recurring service relationships. Industry data indicates that this model is gaining traction, with RaaS fleets growing 31% in 2024.

Expanding Across Automation Markets

The NBR framework is part of a broader expansion for TechForce. The company has been extending its platform beyond hospitality into pharmaceutical, laboratory, semiconductor and industrial automation.

In June, TechForce completed the initial deployment of its LIM-E autonomous laboratory support robot as part of its pharmaceutical automation initiative with Oncotelic Therapeutics. A subsequent phase involved deployment of its PUR-E clean-room support robot at a sterile injectable cGMP facility, expanding the company’s exposure to regulated pharmaceutical manufacturing environments.

TechForce has also established a strategic relationship with Taiwan-based Jiun Jiang Enterprise, targeting semiconductors, advanced packaging, precision automation and industrial manufacturing applications. The companies are evaluating potential additional manufacturing capacity in Taiwan and the United States as demand develops across these markets.

That diversification could make the coordination layer increasingly relevant. Different industries may require different machines and workflows, but the underlying challenge remains similar: connecting autonomous systems so they can operate efficiently within a larger environment.

The Opportunity Beyond the Robot

For investors, the larger opportunity may therefore extend beyond individual robotic systems.

TechForce is building a platform that combines robotics, AI-enhanced software, real-world deployments and a coordination layer designed to connect machines across operational environments. If the technology can support third-party systems as intended, the addressable opportunity could extend beyond robots manufactured or deployed directly by TechForce.

The distinction is becoming increasingly important as the robotics industry moves from isolated demonstrations toward real-world deployment. Industrial installations reached 542,000 units globally in 2024, while labor shortages continue pushing operators toward automation.

The next phase of robotics may consequently depend not only on how capable individual machines become, but on how effectively those machines can work together.

TechForce Robotics is positioning its Robotic Connective Network around that challenge while simultaneously expanding into the commercial and industrial environments where coordinated automation could have its greatest impact. If the company can translate its technology into repeatable deployments, the coordination layer could become an increasingly important component of its broader robotics and automation platform.

For more information, visit the company’s website at TechForceRobotics.com.

NOTE TO INVESTORS: The latest news and updates relating to NGTF are available in the company’s newsroom at http://ibn.fm/NGTF

• The company began trading on the OTCQB Venture Market on August 21, completing its transition from the OTCID market.
• The move follows the completion of the FINRA Form 211 process, allowing proprietary broker-dealer quotations in AMFN and potentially broadening market participation.
• The company reported 100 patent applications pending after filing 17 additional U.S. applications covering components and configurations of its Texatron(TM) Fusion Engine(TM) platform.
• American Fusion(TM) has moved the Texatron(TM) program from engineering preparation into active testing, including work at Texas Tech University and continued evaluation of its 500 kW and 5 MW configurations.
• The company is holding preliminary discussions concerning potential power offtake arrangements and Power Purchase Agreements, although no definitive agreements have been signed.

American Fusion(TM) (OTCBQ: AMFN), a developer of next-generation fusion energy technologies, has entered a new phase of its public-market development, with the company beginning trading on the OTCQB Venture Market while simultaneously expanding the intellectual-property portfolio surrounding its Texatron(TM) Fusion Engine(TM).

The OTC move became effective August 21 under the company’s existing ticker, AMFN, after OTC Markets Group approved the upgrade and FINRA processed a Form 211 submitted by Alpine Securities, the company’s sponsoring market maker. American Fusion(TM) had previously traded on the OTCID market (https://ibn.fm/VObmL).

The change is primarily a market-structure development rather than a technology milestone. But for an early-stage energy company seeking capital to fund engineering and commercialization, the distinction matters. Completion of the Form 211 process means proprietary bid and ask quotations can be published in AMFN, rather than the stock being limited to an unsolicited-quotation environment. OTCQB companies are also required to maintain current reporting and satisfy ongoing market and corporate requirements.

American Fusion(TM) became an SEC-reporting company in May after its Form 10 registration statement became effective. Management has described OTCQB as an intermediate stage in a broader capital-markets strategy that could eventually include an application to a national securities exchange. The company has identified the Nasdaq Capital Market and Texas Stock Exchange as potential venues, although no listing has been approved or guaranteed.

The capital-markets development comes as the underlying technology program reaches a more consequential stage.

American Fusion(TM), through its wholly owned Kepler Fusion Technologies business, is developing the Texatron(TM) Fusion Engine(TM) as a modular fusion-energy platform. The company is pursuing an approach based on pulsed electromagnetic compression and has described the platform as intended for aneutronic fusion using deuterium and helium-3.

The central question for investors is no longer simply whether American Fusion(TM) has a conceptual design. It is whether the company can demonstrate the relevant plasma conditions and system performance through controlled testing. That process is underway.

American Fusion(TM) began testing at Texas Tech University in late July, following receipt of a Texas Department of State Health Services certificate covering its registered Texatron(TM) research systems. The initial phase included engineering evaluations, subsystem demonstrations, instrumentation testing and laboratory activities. The company subsequently reported completion of that initial phase.

The company has also continued testing work since then. Its Aug. 27 update said experiments involving 500 kW and 5 MW Texatron(TM) configurations were being used to evaluate progress toward the plasma conditions required for deuterium-helium-3 fusion. American Fusion(TM) also said a new portable vacuum chamber had arrived to support the continuing experimental program.

The company has been explicit that substantial scientific and engineering work remains before it can demonstrate ignition or net energy gain. That qualification is important because testing a fusion device and demonstrating commercially relevant net energy are very different milestones.

The 5 MW pre-production Texatron(TM) is central to the current program. American Fusion(TM) took delivery of the system in June after completing fabrication and modifications, moving the project from prototype development toward installation, commissioning and integrated testing.

Regulatory preparation has advanced alongside the engineering work. The Texas DSHS certificate issued in July covers 12 registered Texatron(TM) model classes ranging from 500 kW to 1 GW for research and development activities, subject to the conditions of the registration.

Meanwhile, the company has continued to expand its intellectual property. On August 24, American Fusion(TM) announced that it had reached a key milestone of 100 pending patent applications after filing 17 additional U.S. applications (https://ibn.fm/zNXIN). The new filings address areas including aluminum fusion-confinement structures, rifled toroidal chambers, electromagnetic-field structures, fuel-injection systems and coil configurations.

The distinction between pending applications and granted patents is important. The filings do not establish that the inventions will ultimately receive patent protection, nor do they demonstrate that the underlying technology is commercially viable. They do, however, show that American Fusion(TM) is attempting to protect the Texatron(TM) concept across multiple configurations rather than treating the technology as a single reactor design.

American Fusion(TM) is also beginning to address the other side of commercialization: potential customers. The company says it is engaged in preliminary discussions regarding prospective electricity offtake arrangements and Power Purchase Agreements for future Texatron(TM)-generated power. No definitive agreements have been executed, and any such arrangements would depend on successful testing, commercialization, regulatory requirements and financing.

The potential customer base is broad. American Fusion has discussed applications involving data centers, industrial facilities, defense and other infrastructure where reliable electricity could be valuable. The company’s July commercialization update highlighted discussions with potential counterparties as testing advanced.

American Fusion(TM) also said it intends to continue using equity financing rather than convertible debt and currently reports no convertible notes outstanding. It is also evaluating a potential Frankfurt quotation or listing to expand its access to European investors, although that initiative remains subject to eligibility and regulatory requirements.

“We have financed the company through equity, funded our operating requirements without relying on convertible debt, continued advancing the Texatron(TM), and built the corporate infrastructure necessary to reach this point,” said CEO Richard Hawkins. “OTCQB is an important milestone, but it is also part of a much larger plan to position American Fusion for the capital markets and commercial opportunities ahead.”

For more information, visit the company’s website at www.AmericanFusionEnergy.com.

NOTE TO INVESTORS: The latest news and updates relating to AMFN are available in the company’s newsroom at https://ibn.fm/AMFN